CD274 and neoplasm: First, we analyzed the percentages of tumor cells expressing PD-L1 by immunohistochemistry (IHC) and multiplex immunofluorescence (mIF) staining in available tumor samples resected after ICI therapy from NIF and No-NIF patients.